InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2024-06-03 00:00:00 ET · period of report 2024-06-01 · accession 0001576280-24-000124 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-03 2024-06-01 GH Chudova Darya CTO F - Tax $27.10 -113 43.2K -0.3% -$3,062
D 2024-06-03 2024-06-01 GH Chudova Darya CTO M - OptEx $0.00 +315 43.3K +0.7% $0
D 2024-06-03 2024-06-01 GH Chudova Darya CTO M - OptEx $0.00 -315 1,579 -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-01 F D 113 $27.10 43,202 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2 Common Common Stock 2024-06-01 M A 315 $0.00 43,315 D — —
3 Derivative Restricted Stock Units 2024-06-01 M D 315 $0.00 1,579 D $0.00 · — to — 315 Common Stock (F2) The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025. (F3) Not applicable for Restricted Stock Units.